Two doses of the AstraZeneca vaccine were 60 per cent effective against symptomatic disease from the India variant compared with 66 per cent effectiveness against the Kent variant.
Two COVID-19 shots effective against U.K., India variants: study
Two doses of the AstraZeneca vaccine were 60 per cent effective against symptomatic disease from the India variant compared with 66 per cent effectiveness against the Kent variant.